Dynamics Between Affect and Social Acceptance as a Function of Social Anxiety: A Person-Specific Network Approach
Gunther K, Edelman A, Petrie D, Kober H, Gee D, Joormann J, Gadassi-Polack R. Dynamics Between Affect and Social Acceptance as a Function of Social Anxiety: A Person-Specific Network Approach. Emotion 2024 PMID: 39207390, DOI: 10.1037/emo0001370.Peer-Reviewed Original ResearchEtiology of social anxiety disorderSocial anxiety disorderSocial anxietyPositive affectAnxiety disordersDevelopmental period of increased riskFunction of social anxietySocial anxiety symptomsDaily diary dataSocial acceptanceBenefits of acceptanceSocial experiencePerson-centered approachPeriod of increased riskRegulate affectAnxiety symptomsSocial cuesAnxietyAffectDevelopmental periodPerson-specificAdolescentsDiary dataReturn to baselineDisordersNeuromarkers in addiction: definitions, development strategies, and recent advances
Harp N, Wager T, Kober H. Neuromarkers in addiction: definitions, development strategies, and recent advances. Journal Of Neural Transmission 2024, 131: 509-523. PMID: 38630190, DOI: 10.1007/s00702-024-02766-2.Peer-Reviewed Original ResearchConceptsSubstance use disordersFeatures of substance use disordersResponse to treatmentNeurobiological basisAddiction neuroscienceIndividual treatment outcomesPsychiatric conditionsDetecting response to treatmentPsychological phenomenaNeuromarkersIndex riskSeverity of pathologyTreatment outcomesAbnormal processingAddictionPutative markerClinical practiceStable indicatorSevere pathologyAssess riskNeurosciencePathologyReview recent advancesDisordersTreatmentParameter Space and Potential for Biomarker Development in 25 Years of fMRI Drug Cue Reactivity
Network A, Sangchooli A, Zare-Bidoky M, Jouzdani A, Schacht J, Bjork J, Claus E, Prisciandaro J, Wilson S, Wüstenberg T, Potvin S, Ahmadi P, Bach P, Baldacchino A, Beck A, Brady K, Brewer J, Childress A, Courtney K, Ebrahimi M, Filbey F, Garavan H, Ghahremani D, Goldstein R, Goudriaan A, Grodin E, Hanlon C, Haugg A, Heilig M, Heinz A, Holczer A, Van Holst R, Joseph J, Juliano A, Kaufman M, Kiefer F, Zonoozi A, Kuplicki R, Leyton M, London E, Mackey S, McClernon F, Mellick W, Morley K, Noori H, Oghabian M, Oliver J, Owens M, Paulus M, Perini I, Rafei P, Ray L, Sinha R, Smolka M, Soleimani G, Spanagel R, Steele V, Tapert S, Vollstädt-Klein S, Wetherill R, Witkiewitz K, Yuan K, Zhang X, Verdejo-Garcia A, Potenza M, Janes A, Kober H, Zilverstand A, Ekhtiari H. Parameter Space and Potential for Biomarker Development in 25 Years of fMRI Drug Cue Reactivity. JAMA Psychiatry 2024, 81: 414-425. PMID: 38324323, PMCID: PMC11304510, DOI: 10.1001/jamapsychiatry.2023.5483.Peer-Reviewed Original ResearchTreatment developmentNeurobiology of drug addictionDrug cue reactivitySubstance use disordersBiomarkers of addictionCue reactivityAddictive disordersBiomarker developmentDrug addictionTreatment responseTreatment outcomesVisual cuesTask designCore aspectsAddictionClinical judgmentParticipant characteristicsDisordersOutcome predictorsClinical useMEDLINE databaseBiomarker qualificationSeveral biomarkersTranslational gapDatabase inception